AMINOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,426 KRW | -1.45% |
|
-4.49% | +6.10% |
| 2023 | Aminologics Co.,Ltd.(KOSDAQ:A074430) dropped from S&P Global BMI Index | CI |
| 2023 | Aminologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 150,623 | 171,701 | 236,254 | 192,780 | 160,723 | 118,039 |
| Enterprise Value (EV) 1 | 129,735 | 148,790 | 212,551 | 168,770 | 133,474 | 91,360 |
| P/E ratio | 18.8 x | -143 x | 110 x | 36 x | -22.1 x | 48.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 8.16 x | 9.05 x | 13.4 x | 8.44 x | 5.88 x | 5.65 x |
| EV / Revenue | 7.03 x | 7.84 x | 12 x | 7.39 x | 4.88 x | 4.37 x |
| EV / EBITDA | 17.4 x | -268 x | 75.6 x | 39.9 x | 18.4 x | 47.9 x |
| EV / FCF | 30.5 x | 33.1 x | 1,924 x | -107 x | 163 x | -45.6 x |
| FCF Yield | 3.28% | 3.02% | 0.05% | -0.93% | 0.61% | -2.19% |
| Price to Book | 2.83 x | 3.31 x | 4.41 x | 3.25 x | 3.13 x | 2.17 x |
| Nbr of stocks (in thousands) | 87,827 | 87,827 | 87,827 | 87,827 | 87,827 | 87,827 |
| Reference price 2 | 1,715 | 1,955 | 2,690 | 2,195 | 1,830 | 1,344 |
| Announcement Date | 19/03/19 | 16/03/20 | 15/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 18,450 | 18,980 | 17,651 | 22,849 | 27,337 | 20,887 |
| EBITDA 1 | 7,469 | -555.7 | 2,811 | 4,232 | 7,259 | 1,908 |
| EBIT 1 | 7,334 | -822.3 | 2,584 | 3,953 | 6,908 | 1,462 |
| Operating Margin | 39.75% | -4.33% | 14.64% | 17.3% | 25.27% | 7% |
| Earnings before Tax (EBT) 1 | 7,982 | -1,201 | 2,074 | 3,704 | -6,281 | 2,291 |
| Net income 1 | 7,996 | -1,201 | 2,140 | 5,360 | -7,282 | 2,436 |
| Net margin | 43.34% | -6.33% | 12.12% | 23.46% | -26.64% | 11.66% |
| EPS 2 | 91.05 | -13.67 | 24.37 | 61.03 | -82.91 | 27.74 |
| Free Cash Flow 1 | 4,250 | 4,495 | 110.5 | -1,572 | 819.1 | -2,002 |
| FCF margin | 23.04% | 23.68% | 0.63% | -6.88% | 3% | -9.59% |
| FCF Conversion (EBITDA) | 56.9% | - | 3.93% | - | 11.28% | - |
| FCF Conversion (Net income) | 53.15% | - | 5.16% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19/03/19 | 16/03/20 | 15/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 20,888 | 22,912 | 23,703 | 24,010 | 27,249 | 26,680 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 4,250 | 4,495 | 110 | -1,572 | 819 | -2,002 |
| ROE (net income / shareholders' equity) | 16.3% | -2.29% | 4.06% | 9.49% | -13.1% | 4.6% |
| ROA (Net income/ Total Assets) | 8.63% | -0.9% | 2.74% | 3.94% | 7.15% | 1.61% |
| Assets 1 | 92,656 | 133,933 | 78,121 | 135,978 | -101,883 | 150,968 |
| Book Value Per Share 2 | 606.0 | 590.0 | 610.0 | 676.0 | 585.0 | 620.0 |
| Cash Flow per Share 2 | 133.0 | 92.70 | 97.70 | 101.0 | 145.0 | 137.0 |
| Capex 1 | 231 | 100 | 309 | 516 | 490 | 156 |
| Capex / Sales | 1.25% | 0.53% | 1.75% | 2.26% | 1.79% | 0.75% |
| Announcement Date | 19/03/19 | 16/03/20 | 15/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +6.10% | 90.5M | |
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
- Stock Market
- Equities
- A074430 Stock
- Financials Aminologics Co.,Ltd.
